151 related articles for article (PubMed ID: 37980554)
1. [Screening and activity analysis of nanobodies against lymphocyte activation gene-3(LAG-3)].
Wen R; Chen Y; Yang Z; Yan F; Li Q; Wu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):1024-1031. PubMed ID: 37980554
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a novel nanobody with SRMV neutralizing activity.
Sun M; Wang C; Luo H; Chen Y; Qu G; Chen J; Li L; Zhang M; Xue Q
Microb Cell Fact; 2024 Feb; 23(1):45. PubMed ID: 38341572
[TBL] [Abstract][Full Text] [Related]
3. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
5. Construction of an alpaca immune antibody library for the selection of nanobodies against
Qiu J; Li J; Zhang Z; Dong S; Ling X; Fang Z; Ling Q; Huang Z
Front Bioeng Biotechnol; 2023; 11():1207048. PubMed ID: 37362207
[No Abstract] [Full Text] [Related]
6. [Screening, expression and characterization of anti-human CD20 nanobodies].
Li Y; Li G; Wang H; Jiang D; Chu Y; Zhang A; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):67-72. PubMed ID: 33441230
[TBL] [Abstract][Full Text] [Related]
7. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody].
Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599
[TBL] [Abstract][Full Text] [Related]
8. [Prokaryotic expression of prostate-specific membrane antigen (PSMA) nanoantibody gene and screening of natural phage nanoantibody library].
Zhang X; Chen K; Jiang K; He J; An Y; He Z; Sun F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Nov; 38(11):1030-1035. PubMed ID: 36328433
[TBL] [Abstract][Full Text] [Related]
9. An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens.
Tsukahara N; Murakami A; Motohashi M; Nakayama H; Kondo Y; Ito Y; Azuma T; Kishimoto H
Int Immunol; 2022 Jul; 34(8):421-434. PubMed ID: 35689594
[TBL] [Abstract][Full Text] [Related]
10. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
11. Development and production of nanobodies specifically against green fluorescence protein.
Fang Z; Cao D; Qiu J
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
[TBL] [Abstract][Full Text] [Related]
12. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of interleukin-1β-targeted nanobodies and their effects on apoptosis in hypoxic cardiomyocytes of mice].
Ouyang Q; Wang L; Nasser IDE; Deng G; Zhang XK; You T; Su HT; Zhu P
Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(22):2066-2073. PubMed ID: 38858217
[No Abstract] [Full Text] [Related]
14. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
Ferrari D; Garrapa V; Locatelli M; Bolchi A
Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
[TBL] [Abstract][Full Text] [Related]
15. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
16. A novel nanobody against urease activity of Helicobacter pylori.
Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
[TBL] [Abstract][Full Text] [Related]
17. Characterization of nanobodies binding human fibrinogen selected by E. coli display.
Salema V; López-Guajardo A; Gutierrez C; Mencía M; Fernández LÁ
J Biotechnol; 2016 Sep; 234():58-65. PubMed ID: 27485813
[TBL] [Abstract][Full Text] [Related]
18. Structural Characterization of Humanized Nanobodies with Neutralizing Activity against the Bordetella pertussis CyaA-Hemolysin: Implications for a Potential Epitope of Toxin-Protective Antigen.
Malik AA; Imtong C; Sookrung N; Katzenmeier G; Chaicumpa W; Angsuthanasombat C
Toxins (Basel); 2016 Apr; 8(4):99. PubMed ID: 27043627
[TBL] [Abstract][Full Text] [Related]
19. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
Ji L; Dong C; Fan R; Qi S
Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
[TBL] [Abstract][Full Text] [Related]
20. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.
Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R
J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
